DEVAJIT MOHAJAN; HARADHAN KUMAR MOHAJAN. Alpha-Glucosidase Inhibitors (AGIs): A New Class of Oral Medication for Treatment of Type 2 Diabetes Patients. Journal of Innovations in Medical Research, [S. l.], v. 3, n. 4, p. 1–6, 2024. Disponível em: https://www.paradigmpress.org/jimr/article/view/1381. Acesso em: 30 apr. 2025.